{"id":"W4401876465","doi":"10.1016/s2152-2650(24)01517-9","title":"ABCL-340 Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase 2 Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Chimeric antigen receptor; Refractory (planetary science); Phases of clinical research; Oncology; Lymphoma; Internal medicine; Cancer research; Immunotherapy; Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003322689,0.001699838,0.003593126,0.0005999014,0.000410202,0.001600294,0.0007969551,0.001032174,0.00197102],"category_scores_gemma":[0.001459383,0.0006241261,0.004145746,0.0008440503,0.0006392922,0.001432458,0.000551722,0.002087949,0.0004561644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008775648,"about_ca_system_score_gemma":0.0009211084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001049694,"about_ca_topic_score_gemma":0.003084158,"domain_scores_codex":[0.9988418,0.0005151036,0.00006809943,0.0002173584,0.0001020488,0.0002555552],"domain_scores_gemma":[0.9989915,0.0002686896,0.0002552583,0.0001707129,0.00006399876,0.0002498542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8444587,0.003257237,0.05508313,0.0006270263,0.0183289,0.0003177832,0.0001963927,0.002720273,0.01460601,0.0001519033,0.002250883,0.05800173],"study_design_scores_gemma":[0.3740812,0.134415,0.4463997,0.0001489187,0.02947325,0.0007812983,0.0004172237,0.003950598,0.003834535,0.0008251482,0.00544981,0.000223227],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936026,0.004155702,0.000275852,0.0001875415,0.00006153299,0.0001960979,0.0009578149,0.00003724986,0.0005257542],"genre_scores_gemma":[0.9952734,0.001089041,0.0002449539,0.0002795135,0.0000972904,0.0001825069,0.002290948,0.00001676686,0.0005256496],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003593126,"threshold_uncertainty_score":0.01757228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02972376359051035,"score_gpt":0.3459428170538627,"score_spread":0.3162190534633523,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}